GNMT and cancer: To further understand the potential mechanisms that lead to the down-regulation of GNMT in cancer, previous studies of hypermethylation of the GNMT promoter showed that the 3′ region of the TSS of GNMT contained seven CpG sites which were methylated in HCCs (20%)33.